GB202109082D0 - Polypeptides and uses thereof - Google Patents

Polypeptides and uses thereof

Info

Publication number
GB202109082D0
GB202109082D0 GBGB2109082.4A GB202109082A GB202109082D0 GB 202109082 D0 GB202109082 D0 GB 202109082D0 GB 202109082 A GB202109082 A GB 202109082A GB 202109082 D0 GB202109082 D0 GB 202109082D0
Authority
GB
United Kingdom
Prior art keywords
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2109082.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB2109082.4A priority Critical patent/GB202109082D0/en
Publication of GB202109082D0 publication Critical patent/GB202109082D0/en
Priority to PCT/GB2022/051619 priority patent/WO2022269277A1/en
Priority to GB2400924.3A priority patent/GB2623253A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/26—Klebsiella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB2109082.4A 2021-06-24 2021-06-24 Polypeptides and uses thereof Ceased GB202109082D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB2109082.4A GB202109082D0 (en) 2021-06-24 2021-06-24 Polypeptides and uses thereof
PCT/GB2022/051619 WO2022269277A1 (en) 2021-06-24 2022-06-23 Klebsiella pneumoniae klebc polypeptides and uses thereof
GB2400924.3A GB2623253A (en) 2021-06-24 2022-06-23 Klebsiella pneumoniae KlebC polypeptides and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2109082.4A GB202109082D0 (en) 2021-06-24 2021-06-24 Polypeptides and uses thereof

Publications (1)

Publication Number Publication Date
GB202109082D0 true GB202109082D0 (en) 2021-08-11

Family

ID=77179584

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB2109082.4A Ceased GB202109082D0 (en) 2021-06-24 2021-06-24 Polypeptides and uses thereof
GB2400924.3A Pending GB2623253A (en) 2021-06-24 2022-06-23 Klebsiella pneumoniae KlebC polypeptides and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB2400924.3A Pending GB2623253A (en) 2021-06-24 2022-06-23 Klebsiella pneumoniae KlebC polypeptides and uses thereof

Country Status (2)

Country Link
GB (2) GB202109082D0 (en)
WO (1) WO2022269277A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024165442A1 (en) * 2023-02-06 2024-08-15 The University Court Of The University Of Glasgow Anti-bacterial protein complex
WO2024187112A1 (en) * 2023-03-09 2024-09-12 Baylor College Of Medicine Dequalinium chloride as a mutation-slowing drug to inhibit de novo pathogen evolution including evolution of antibiotic resistance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2791895B1 (en) 1999-03-23 2001-06-15 Pasteur Merieux Serums Vacc USE OF TREHALOSE TO STABILIZE A LIQUID VACCINE
WO2009143266A1 (en) * 2008-05-20 2009-11-26 The Uab Research Foundation Targeting the efflux systems of mycobacterium tuberculosis
WO2019116392A1 (en) * 2017-12-14 2019-06-20 Gangagen, Inc. Therapeutic bacteriocins

Also Published As

Publication number Publication date
GB2623253A (en) 2024-04-10
GB202400924D0 (en) 2024-03-06
WO2022269277A1 (en) 2022-12-29

Similar Documents

Publication Publication Date Title
IL284633A (en) Polypeptides comprising modified il-2 polypeptides and uses thereof
IL304469A (en) Reprogrammable tnpb polypeptides and use thereof
IL287781A (en) Clec12a-binding polypeptides and uses thereof
IL287782A (en) Cd33-binding polypeptides and uses thereof
GB202006376D0 (en) Recombinant sars-cov-2 polypeptides and uses
EP4165049A4 (en) Isotryptamine psychoplastogens and uses thereof
IL280808A (en) Ox40-binding polypeptides and uses thereof
EP3813861A4 (en) Heparin-associated polypeptides and uses thereof
GB2600592B (en) Polypeptide and use thereof
GB202109082D0 (en) Polypeptides and uses thereof
GB201819200D0 (en) Polypeptide and uses thereof
EP4178603A4 (en) Mybpc3 polypeptides and uses thereof
GB2603645B (en) Polypeptides having anti-senescent effects and uses thereof
EP4136119A4 (en) Modified ccr polypeptides and uses thereof
GB202012804D0 (en) Agrin polypeptide and uses thereof
IL311185A (en) Mog-binding proteins and uses thereof
EP4175970A4 (en) Peptides and uses thereof
EP4103586A4 (en) Polypeptides and their use
GB202019817D0 (en) Ligand-binding polypeptides and uses thereof
GB202018733D0 (en) Polypeptides and uses thereof
GB202002010D0 (en) Microtopographies and uses thereof
IL309885A (en) Alpha-sheet polypeptides and their use
EP4081235A4 (en) Heparin-associated polypeptides and uses thereof
IL304183A (en) Actinohivin variant polypeptides and related methods
GB202100996D0 (en) Ezrin-derived peptides and uses

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)